La miocarditis es un proceso inflamatorio que afecta al músculo cardiaco. Los síntomas de presentación son poco específicos y su diagnóstico, difícil. El realce de contraste valorado con cardiorresonancia magnética (CRM) es un hallazgo frecuente en la miocarditis que ha demostrado ser de gran utilidad en su diagnóstico y en el seguimiento. El estudio de miocardiopatías es una indicación tradicional de la CRM, pues permite realizar estudios morfológicos y funcionales con mayor resolución especial que el ecocardiograma. Además, las últimas secuencias desarrolladas con contraste ayudan a diferenciar su etiología.
Palabras clave
Miocarditis
Realce de contraste
Cardiorresonancia magnética
Miocardiopatías
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
C. Kishimoto, Y. Hirakoka.
Clinical and experimental studies in myocarditis.
Curr Opin Cardiol, (1994), 9 pp. 349-356
[2.]
K.F. Theleman, J.J. Nuipper, W.C. Roberts.
Acute myocarditis sudden death without heart failure.
Am J Cardiol, (2001), 88 pp. 1078-1083
[3.]
W.J. Brady, J.D. Ferguson, E.A. Ullman, A.D. Perron.
Myocarditis: emergency departament recognition and management.
Emerg Med Clin N Am, (2004), 22 pp. 865-885
[4.]
A. Angelini, V. Calzolari, F. Calabrese, G.M. Boffa, F. Magdalena, R. Chioin, et al.
Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the diferencial diagnosis.
Heart, (2000), 84 pp. 245-250
[5.]
L. Sarda, P. Colin, F. Boccara, D. Daou, R. Lebtahi, M. Faraggi, et al.
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms.
J Am Coll Cardiol, (2001), 37 pp. 786-792
[6.]
P. Veluvolu, A.A. Balian, R. Goldsmith, T.E. Gallant, L. Barthel, H.J. Vidaillet, et al.
Lyme carditis evaluation by Ga-67 and MRI.
Clin Nucl Med, (1992), 17 pp. 823-827
[7.]
U. Kuhl, B. Lauer, M. Souvatzoglu, H. Vosberg, H.P. Schultheiss.
Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with suspected myocarditis: evidence of myocardial cell damage and inflamation in the absence of histologic signs of myocarditis.
J Am Coll Cardiol, (1998), 32 pp. 1371-1376
[8.]
T. Yasuda, I.F. Palacios, G.W. Dec, J.T. Fallon, H.K. Gold, R.C. Leinbach, et al.
Indium 111-monoclonal antimyosin-antibody imaging in the diagnosis of acute myocarditis.
Circulation, (1987), 76 pp. 306-311
[9.]
J. Bergler-Klein, H. Sochor, G. Stanek, S. Globits, R. Ullrich, D. Glogar.
Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme carditis.
Arch Intern Med, (1993), 153 pp. 2696-2700
[10.]
H.T. Aretz, M.E. Billingham, W.D. Edwards, S.M. Factor, J.T. Fallon, J.J. Fenoglio Jr, et al.
Myocarditis: a histopathologic definition and classification.
Am J Cardiovasc Pathol, (1987), 1 pp. 3-14
[11.]
M.G. Friedrich, O. Strohm, J. Shultz-Menger, H. Marciniak, F.C. Luft, R. Dictz.
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in course of viral myocarditis.
Circulation, (1998), 97 pp. 1802-1809
[12.]
N. Kubo, S. Morimoto, S. Hiramitsu, A. Uemura, K. Kimura, K. Shimizu, et al.
Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy.
Heart Vessels, (1997), 12 pp. 167-170
[13.]
M.G. Gagliardi, M. Bevilacqua, P. Di Renzi, S. Picardo, R. Passariello, C. Marceletti.
Usefulness of magnetic resonance imaging for the diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy.
Am J Cardiol, (1991), 68 pp. 1089-1091
[15.]
G.H. Roditi, G.G. Hartnell, M.C. Cohen.
MRI changes in myocarditis-Evaluation with spin echo cine MR angiography and contrast enhanced spin echo imaging.
Clinical Radiology, (2000), 55 pp. 752-758
[16.]
H. Abdel-Aty, P. Boyé, A. Zagrosek, R. Wassmuth, A. Kumar, D. Messroghli, et al.
Diagnostic performance of Cardiovascular Magnetic resonance in patients with suspected acute myocarditis. Comparison of Different approaches.
J Am Coll Cardiol, (2005), 45 pp. 1815-1822
[17.]
H. Mahrholdt, C. Goedeke, A. Wagner, G. Meinhardt, A. Athanasiadis, H. Vogelsberg, et al.
Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology.
Circulation, (2004), 109 pp. 1250-1258
[18.]
J.P. Laissy, B. Messin, O. Varenne, B. Iung, D. Karila-Cohen, E. Schouman-Claeys, et al.
MRI of acute myocarditis: A comprehensive approach based on various imaging sequences.
Chest, (2002), 122 pp. 1638-1648
[19.]
A.J. Hauck, D.L. Kearney, W.D. Edwards.
Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis.
Mayo Clin Proc, (1989), 64 pp. 1235-1245
[20.]
J. Shirani, L.J. Freant, W.C. Roberts.
Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy.
Am J Cardiol, (1993), 72 pp. 952-957
[21.]
H. Mahrholdt, A. Wagner, R.M. Judd, U. Sechtem, R.J. Kim.
Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies.
Eur Heart J, (2005), 26 pp. 1461-1474
[22.]
H. Imai, T. Kumai, M. Sekiya, S. Kobayashi, M. Sakakibara, Y. Imazeki, et al.
Left ventricular trabeculae evaluated with MRI in dilated cardiomyopathy and old myocardial infarction.
J Cardiol, (1992), 22 pp. 83-90
[23.]
E. Wu, R.M. Judd, J. Vargas.
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
Lancet, (2001), 357 pp. 21-28
[24.]
D. Bello, D.J. Shah, G.M. Farah.
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
Circulation, (2003), 108 pp. 1945-1953
[25.]
E.H. Schuster, B.H. Bulkley.
Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients.
Am Heart J, (1980), 100 pp. 506-512
[26.]
W.C. Roberts, R.J. Siegel, B.M. McManus.
Idiopathic dilated cardiomyopath: analysis of 152 necropsy patients.
Am J Cardiol, (1987), 60 pp. 1340-1355
[27.]
J.A. McCrohon, J.C. Moon, S.K. Prasad, W.J. McKenna, C.H. Lorenz, A.J. Coats, et al.
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance.
Circulation, (2003), 108 pp. 54-59
[28.]
J. Bogaert, A.M. Taylor, F. Van Kerckhove, S. Dymarkowski.
Use of inversion-recovery contrast-enhanced MRI technique for cardiac imaging: spectrum of diseases.
Am J Roentgenol, (2004), 182 pp. 609-615
[29.]
P.D. Bergey, L. Axel.
Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis.
Am J Roentgenol, (2000), 174 pp. 242-244
[30.]
A.A. Young, C.M. Kramer, V.A. Ferrari, L. Axel, N. Reichek.
Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy.
Circulation, (1994), 90 pp. 854-867
[31.]
C. Rickers, N.M. Wilke, M. Jerosch-Herold, S. Casey, P. Panse, N. Panse, et al.
Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
Circulation, (2005), 112 pp. 855-861
[32.]
J.C.C. Moon, W.J. McKenna, J.A. McCrohon.
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
J Am Coll Cardiol, (2003), 41 pp. 1561-1567
[33.]
A.M. Varnava, P.M. Elliot, S. Sharma, W.J. McKenna, M.J. Davies.
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.
Heart, (2000), 84 pp. 476-482
[34.]
W.G. Van Dockum, F.J. Ten Cate, J.M. Ten Berg, A.M. Beek, J.W. Twisk, J. Vos, et al.
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
J Am Coll Cardiol, (2004), 43 pp. 27-34
[35.]
A.M. Maceira, J. Joshi, S.K. Prasad.
CMR in Amyloidosis.
Circulation, (2005), 111 pp. 186-193
[36.]
L.J. Anderson, S. Holden, B. Davis, E. Prescott, C.C. Charrier, N.H. Bunce, et al.
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.
Eur Heart J, (2001), 22 pp. 2171-2179
[37.]
M. Westwood, L.J. Anderson, D.N. Firmin, P.D. Gatehouse, C.C. Charrier, B. Wonke, et al.
A single breath-hold multi-echo T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.
J Magn Reson Imaging, (2003), 18 pp. 33-39
[38.]
E.S. Siegelman, D.G. Mitchell, R.C. Semelka.
Abdominal iron deposition: metabolism, MR findings, and clinical importance.
Radiology, (1996), 199 pp. 13-22
[39.]
P. Richardson, W. McKenna, M. Bristow, B. Maisch, B. Mautner, J. O’Connell, et al.
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.
Circulation, (1996), 93 pp. 841-842
[40.]
L.M. Blake, M.M. Scheinman, C.B. Higgins.
MR features of arrhythmogenic right ventricular dysplasia.
AJR Am J Roentgenol, (1994), 162 pp. 809-812
[41.]
M. Midiri, M. Finazzo, M. Brancato, E. Hoffmann, G. Indovina, M.D. Maria, et al.
Arrhythmogenic right ventricular dysplasia: MR features.
Eur Radiol, (1997), 7 pp. 307-312
[42.]
D.A. Bluemke, E.A. Krupinski, T. Ovitt, K. Gear, E. Unger, L. Axel, et al.
MR imaging on arrhythmogenic right ventricular cardiomyopathy: morphological findings and interobserver reliability.
Cardiology, (2003), 99 pp. 153-162
[43.]
G. Aviram, J.E. Fishman, M.L. Young, E. Redha, G. Biliciler-Denktas, M.M. Rodriguez.
MR evaluation of arrhythmogenic right ventricular cardiomyopathy in pediatric patients.
Am J Roetgnenol, (2003), 180 pp. 1135-1141
[44.]
H. Tandri, C. Martinez, M. Saranathan.
Non-invasive detection of myocardial fibrosis in arrythmogenic right ventricular dysplasia by delayed enhancement magnetic resonance imaging correlation with histopathology [abstract].
J Cardiovasc Magn Reson, (2004), 6 pp. 44-45
[45.]
C.E. Rochitte, P.F. Olivera, M. Joalbo.
Chagas disease is characterized by specific pattern and location of myocardial delayed enhanced MRI [abstract].
J Cardiovasc Magn Reson, (2003), 5 pp. 115
[46.]
J.C. Moon, B. Sachdev, A.G. Elkington.
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.
Eur Heart J, (2003), 24 pp. 2151-2155
[47.]
O. Vignaux, R. Dhote, D. Duboc.
Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study.
J Comput Assist Tomogr, (2002), 26 pp. 762-767
[48.]
M.R. Patel, P.J. Cawely, J.F. Heitner.
Improved diagnostic sensitivity of contrast enhanced cardiac MRI for cardiac sarcoidosis [abstract].
Circulation, (2004), 108 pp. 645
[49.]
O. Vignaux, R. Dhote, P. Blanche.
Myocardial MRI in sarcoidosis: 3- years follow-up and evaluation of the effects of steroid therapy [abstract].
J Cardiovasc Magn Reson, (2004), 6 pp. 44
[50.]
L.J.J. Borreguero, R. Corti, R.F. Soria.
Diagnosis of noncompactation of the myocardium by magnetic resonance imaging.
Circulation, (2004), 105 pp. e177-e178
[51.]
D. Penell, U. Sechtem, C. Higgins, W. Manning, G. Pohost, F. Rademakers, et al.
Clinical indications for cardiovascular magnetic resonance: Consensus panel report.
Eur Heart J, (2004), 25 pp. 1940-1965
Copyright ©
2006. Sociedad Española de Cardiología